Geneva, May 29 -- International Clinical Trials Registry received information related to the study (ChiCTR2600125062) titled 'Application of Remimazolam Combined with Remifentanil in Hysteroscopic Anesthesia : a non-inferiority randomized controlled trial' on May 20.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: The Second Nanning People's Hospital (The Third Affiliated Hospital of Guangxi Medical University)
Condition:
no
Intervention:
Trial group: remimazolam was chosen as sedative drugs for anesthesia introdution and maintenance
Recruitment Status: Not Recruiting
Phase: 0
Date of First Enrollment: 2023-04-17
Target Sample Size: Trial group:106;Control group:105;
Countries of Recruitment:
Ch...